Compare IDEXX Laboratories, Inc. (IDXX) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Qurate Retail Inc Series A — how do they compare? IDEXX Laboratories, Inc. trades at $551.53 (market cap $44.48B), while Qurate Retail Inc Series A trades at $0.04 (market cap $698.27K). The key difference: IDEXX Laboratories, Inc. is far larger — about 63700.3× Qurate Retail Inc Series A's market cap, and IDEXX Laboratories, Inc. is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| IDXX | QVCAQ | |
|---|---|---|
Market Cap | $44.48B | $698.27K |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $15.03 |
52-Week Low | $520.87 | $0.05 |
Enterprise Value | $45.38B | $4.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
QVCAQ trades at $0.05, down 14.68% today, reflecting severe financial distress with negative equity and consecutive annual losses. The stock shows a bearish technical signal, with most moving averages indicating sell pressure. Recent cash flow improvements stem from financing activities, not operations. The company celebrated 40 years of innovation with a TikTok Shop event, but fundamentals remain weak.
Outlook is highly risky due to persistent net losses, declining revenue, and negative shareholder equity. Investment opportunity is minimal without a turnaround in profitability. Key risks include high debt burden, competitive pressures in retail, and inability to achieve sustained earnings growth. Investors should avoid until operational stability is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
